Division of Drugs@

Japanese


The division consists of three sections engaged in research work related to chemical analysis and pharmaceutical (biological and physico-chemical) evaluation of drugs and their preparations, as well as evaluation of specifications submitted for new drug applications.


Announcement

  • Pharmaceutical Development and GMP
    Response to the feedback on Mock P2 with Enhanced Approach(2010)
    ------English Mock QOS P2 Revised version(2010)------
    ------English Mock Application Form(2010)------
    Pharmaceutical Development P2 with Enhanced Approach(2008)
    ------Mock P2 English(FileC)(2008)------
    Draft GMP Guidelines For Comments (2004)

  • Bioequivalence
    Guideline for Bioequivalence Studies of Generic Products for Topical Use (2003) (pdf file)
    Guideline for Bioequivalence Studies for Different Strengths of Oral Solid Dosage Forms (2006) (pdf file)
    Guideline for Bioequivalence Studies for Formulation Changes of Oral Solid Dosage Forms (2006) (pdf file)
    Guideline for Bioequivalence Studies of Generic Products (2006)(pdf file)
    Old guidelines (BE guiide 1997 | formulation change 2000 | different strength 2000)

  • Others
    Bioanalytical Method Validation and related areas.
    Validation of Analytical Procedures: Methodology (1996) Step 4, Consensus Guideline (obtained from EMEA)
    Guidelines for the Design and Evaluation of Oral Prolonged Release Dosage Forms (1988) (pdf file)
  • First Section
    Second Section
    Third Section
    Fourth Section

    To NIHS Home

    Last edition: Jan. 18, 2011